Tenaya Therapeutics (TNYA)
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead...
- Open
- 0.7301
- High
- 0.7510
- Low
- 0.7200
- Prev. Close
- 0.7268
- Volume
- 2.40M
- Turnover
- 1.76M
- Avg Price
- 0.7317
- Bid/Ask Ratio
- --
- Amplitude
- 4.27%
- 52wk High
- 2.3500
- Volume Ratio
- 1.74
- Turnover Ratio
- 1.44%
Tenaya Therapeutics Analyst Rating
View moreForecast & Rating
Aug 6, 2026Price forecast
$3.20333.96%
Forecast & RatingStrong buy
7analysts
- Strong buy71.43%
- Buy28.57%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Aug 5 at 12:56 AM
Tenaya Therapeutics (TNYA) to Post Earnings on Wednesday
- PUBT · Aug 4 at 03:22 PM
Tenaya Therapeutics to join Canaccord Genuity Growth Conference fireside chat, investor meetings
- Global Report · Jul 24 at 04:13 AM
Life Beyond the Megacaps: The Complex Reality of 2026's Market Misfits
- PUBT · Jul 14 at 08:04 PM
Tenaya Therapeutics CFO Eric J. Hyllengren files initial beneficial ownership statement
- PUBT · Jul 14 at 08:00 PM
Tenaya Therapeutics grants CFO Hyllengren options to buy 1.65 million shares at $0.84 each
- StockTitan · Jul 14 at 12:00 PM
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | TNYA Stock News
